Logo for Portage Biotech Inc

Portage Biotech Investor Relations Material

Latest events

Logo for Portage Biotech

Q1 2025

27 Aug, 2024
Logo for Portage Biotech

Q4 2024

15 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Portage Biotech Inc

Access all reports
Portage Biotech Inc. is a clinical-stage biopharmaceutical company focused on the development of innovative immuno-oncology treatments. The company is focused on advancing first-in-class therapies that target checkpoint resistance pathways, with the goal of achieving durable treatment responses and improving the quality of life for patients with cancer. Portage Biotech's approach aims to address the limitations of current cancer therapies by offering potentially more effective treatment options. The company's research and development efforts are concentrated on novel multi-targeted therapies that can be used both as monotherapies and in combination with other treatments to combat cancer more effectively. The company is headquartered in Westport, Connecticut, and its shares are listed on the Nasdaq.